Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study
Hartmut Goldschmidt ; Philippe Moreau ; Heinz Ludwig ; Ruben Niesvizky ; Wee Joo Chng ; Douglas Joshua ; Katja Weisel ; Andrew Spencer ; Robert Orlowski ; Shibao Feng ... show 2 more
Hartmut Goldschmidt
Philippe Moreau
Heinz Ludwig
Ruben Niesvizky
Douglas Joshua
Katja Weisel
Andrew Spencer
Robert Orlowski
Shibao Feng
Citations
Altmetric:
Alternative Title
Abstract
Keywords
Source Title
Leukemia & Lymphoma
Publisher
Taylor & Francis
Series/Report No.
Collections
Rights
Date
2017-09-22
DOI
10.1080/10428194.2017.1376743
Type
Others